Sign In
NewsRadar

Minoryx Therapeutics

Minoryx develops a small molecule drugs named pharmacological chaperones, which are a approach to treat genetic diseases affecting the central nervous system.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Web:
Contact:
 
 
Ernest Lluch 32
Barcelona 08302
Spain
+34 93 702 19 75
http://minoryx.com
Marc Martinell
+34 93 702 19 75

Company Facts
Founded:Jun 2011
Founders:Marc Martinell
CEO:Marc Martinell
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biotechnology
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


24,413
Tech investments
From our Online Data Service
15,788
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Jun 19€13.0MInternet services
Jun 19€2.5MOther Biotechnology & Healthcare
Jun 19€5.0MMedical devices
Jun 18€3.0MSecurity
Jun 18€12.0MApplication integration
Jun 18€2.0MContent management
Jun 18€1.6MContent distribution

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises 37.5 million in series a





About usContact usLegal Information
Copyright 1999-2018
Emerging Technology Research Europe Inc. All rights reserved.